HOME
WHO IS BDA
BDA DELIVERS
KEY PROJECTS
REFERENCE WORK 
PRINCIPALS & ASSOCIATES
CONTACT US 
Business Development Advisors
Reference Work

StanGraft, Inc. has developed an innovative stent technology that addresses a key unmet clinical need in the minimally invasive stent and stent-graft markets. With its proprietary ultra low-profile design resulting in a 10:1 expansion ratio, the StanGraft stent has the potential to significantly expand the population of patients eligible for minimally invasive procedures. Applications for the StanGraft technology include, but are not limited to, thoracic and abdominal aortic aneurysm stent-grafts, coronary and non-coronary vascular stents, and non-vascular applications such as tracheobronchial stents.

How Sourced: Venture Capital Investor

Our involvement: Developed presentation and offering document; contacted big cardiovascular device manufacturers for sale of technology.